Trademarkia Logo

Australia

AU$
NUTCRACKER
Protected: Registered/protected

Last updated on 20 Sept 2022

Owner Info

Nutcracker Therapeutics, Inc.

5858 Horton Street, Suite 540

Emeryville CA 94608, UNITED STATES OF AMERICA

Serial Number

2199953 filed on 17 Mar 2021

Correspondent

Susan E. Farley Heslin Rothenberg Farley & Mesiti P.C.

5 Columbia Circle,

Albany NY 12203,

UNITED STATES OF AMERICA

NUTCRACKER

Classification Information


Class [001]
Active chemical ingredients, including m-RNA, for use in the manufacture of anti-cancer drugs; chemical solutions and preparations consisting of pre-m Read More

Class [005]
Macromolecules, namely, nucleic acid sequences and proteins, used for medical purposes; nucleic acid sequences and chemical reagents for medical purpo Read More

Class [009]
Cartridges and DNA chips to receive and preserve biological samples for use in RNA transcription; scientific apparatus and instruments for manufacturi Read More

Class [035]
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, b Read More

Class [042]
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; DNA analysis services for scientific Read More

Class [044]
Medical services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases and immunological Read More

Mark Details


Serial Number

2199953

Registered On

16 Mar 2021

Renewal On

17 Mar 2031

Mark Type

WORD

Priority Claim (Convention Details)


Date

23 Sept 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
20th Sept 2022International Registration in Australia Protected After Adverse (No amendments) correspondence sent
19th Sept 2022International Registration in Australia Protected After Adverse (No amendments) correspondence sent
19th Sept 2022IP Right Registration Published
19th Sept 2022Status change to Registered/Protected
6th Aug 2022IRDA - Opposition Still Possible Notice correspondence sent
13th Jul 2022Application Accepted correspondence sent
12th Jul 2022Application Accepted correspondence sent
12th Jul 2022IP Right has been Examined
12th Jul 2022IP Right Acceptance Published
12th Jul 2022Status change to Accepted